Prostate Cancer - Results from #28160

AUA 2011 - Exploratory efficacy analysis conducted for long-term extension study in patients with prostate cancer treated with Firmagon® or crossed over to Firmagon from leuprolide - Press Release May 19, 2011

AUA 2011 - The VA/NCI/AHRQ CSP#407: Prostate Cancer Intervention Versus Observation Trial (PIVOT): Main results from a randomized trial comparing radical prostatectomy to watchful waiting in men with clinically localized prostate cancer - Session Highligh May 19, 2011

AUA 2011 - Content and construct validation of robotic surgery curriculum using electromagnetic instrument tracker - Session Highlights May 18, 2011

AUA 2011 - Value of early confirmatory biopsies and centralized pathological review to select prostate cancer patients for active surveillance - Session Highlights May 18, 2011

AUA 2011 - Long term complications in men after radical prostatectomy who have early or late radiation - Session Highlights May 18, 2011

AUA 2011 - 5-alpha reductase inhibitors diminish the rate of progression in men with low risk prostate cancer on active surveillance - Session Highlights May 18, 2011

AUA 2011 - Age and aggressive prostate cancer in patients with low risk characteristics. Implications for conservative management - Session Highlights May 18, 2011

AUA 2011 - Previously developed systems-based biopsy model (Prostate Px+) identifies favorable-risk prostate cancer for men enrolled in an active surveillance program - Session Highlights May 18, 2011

AUA 2011 - Effect of radical prostatectomy on penile shortening - Session Highlights May 18, 2011

AUA 2011 - Characterization of ureter, bladder, and bowel tissue injury after compression with robotic instruments - Session Highlights May 18, 2011

AUA 2011 - Postoperative pain after pure and robot-assisted laparoscopic radical prostatectomy. A prospective randomized study - Session Highlights May 18, 2011

AUA 2011 - Abiraterone acetate plus low-dose prednisone has a favorable safety profile, improves survival and produces PSA and radiographic responses in metastatic castration-resistant prostate cancer progressing after docetaxel-based chemotherapy: Result May 17, 2011

AUA 2011 - Regulatory role of miR-203 in prostate cancer progression and metastasis - Session Highlights May 17, 2011

AUA 2011 - Utilizing metformin to enhance the efficacy of androgen deprivation therapy in the treatment of prostate cancer - Session Highlights May 17, 2011

AUA 2011 - Phase III study of intermittent MAB vs. continuous MAB - Session Highlights May 17, 2011

AUA 2011 - Avoiding androgen deprivation therapy in men with high risk prostate cancer: The role of radical prostatectomy as initial treatment - Session Highlights May 17, 2011

AUA 2011 - Target specific and dye encapsulated micelle probes for the detection of extra-prostate cancer during robotic-assisted laparoscopic prostatectomy (RALP) - Session Highlights May 17, 2011

AUA 2011 - Current treatment patterns and characteristics of castration resistant prostate cancer (CRPC) patients; a European survey - Session Highlights May 17, 2011

AUA 2011 - Can an early PSA rule out subsequent advanced prostate cancer? Long term risk of advanced cancer in men with low PSA levels at age below 50 - Session Highlights May 17, 2011

AUA 2011 - The value of computed tomography in detecting prostate cancer lymph node metastasis is limited even in contemporary patients with very high risk of nodal involvement - Session Highlights May 17, 2011

Page 1409 of 1447